Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Rocha, F. Costa, J. E. Façanha Barreto (Fortaleza, Brazil). Central venous-to-arterial carbon dioxide difference (CO2 GAP) in patients with arterial pulmonary hypertension: A pilot study. Eur Respir J 2012; 40: Suppl. 56, 3920

Member's Comments

No comment yet.

Related content which might interest you: Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients Source: Eur Respir J 2011; 39: 119-124 Year: 2012 Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients Source: Eur Respir J 2012; 39: 119-124 Year: 2012 Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension Source: Eur Respir J 2007; 29: 944-950 Year: 2007 Slope of exercise ventilation to carbon dioxide production in patients with pulmonary arterial hypertension, either primary or associated with connective tissue disease Source: Annual Congress 2008 - Pulmonary mechanics and gas exchange Year: 2008 Pulmonary gas exchange Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-36-7, page=106 Year: 2005 Ventilatory inefficiency relative to oxygen uptake and carbon dioxide output are independent predictors of mortality in pulmonary arterial hypertension Source: Annual Congress 2013 –Respiratory physiology in health and disease Year: 2013 Prognostic value of end-tidal partial pressure of carbon dioxide during cardiopulmonary exercise test in pulmonary hypertension Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 Noninvasive measurement of mean alveolar carbon dioxide tension and Bohr's dead space during tidal breathing Source: Eur Respir J 2001; 17: 1167-1174 Year: 2001 EARLIER: End tidal carbon dioxide for earlier detection of pulmonary hypertension Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Clinical usefulness of the measurement of percutaneous partial pressure of carbon dioxide in respiratory patients Source: Annual Congress 2012 - Mechanics, muscles and movement: aspects of airway mechanics, repiratory muscle assessment and field exercise tests Year: 2012 Carbon dioxide (CO2) insufflation: a potential source of error in TLCO measurement Source: International Congress 2019 – Quality, performance and interpretation of lung function testing Year: 2019 Comparing the accuracy of inert gas rebreathing (IGR) cardiac output (CO) measurement with invasive measurements in pulmonary hypertension (PH) Source: Annual Congress 2010 - Pulmonary vascular diseases Year: 2010 Relationship of carbon dioxide tension in arterial blood to pulmonary wedge pressure in heart failure Source: Eur Respir J 2002; 19: 37-40 Year: 2002 Clinical meaning of low DLCO in idiopathic pulmonary arterial hypertension (IPAH) - Prospective single centre study Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 The diagnostic value of exhaled carbon monoxide and arterial carboxyhaemoglobin measurements in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 408s Year: 2006 Arterial to end-tidal carbon dioxide measurements in neonates with respiratory disorders Source: Eur Respir J 2002; 20: Suppl. 38, 531s Year: 2002 Acetylene single breath estimation of effective pulmonary blood flow in patients with pulmonary arterial hypertension (PAH) Source: Eur Respir J 2006; 28: Suppl. 50, 423s Year: 2006 Carbon monoxide diffusing capacity and the complexity of diagnosis in pulmonary arterial hypertension Source: Eur Respir J 2014; 43: 963-965 Year: 2014 Noninvasive positive pressure ventilation using helium:oxygen versus air:oxygen in acute respiratory failure in chronic obstructive pulmonary disease patients exposed to sulfur mustard Source: Annual Congress 2008 - Use of noninvasive ventilation in various conditions Year: 2008 Change in diffusing capacity for carbon monoxide as a predictor of outcomes in connective tissue disease-associated pulmonary arterial hypertension: Analysis from the REVEAL registry Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012